Interindividual variations in metabolism and pharmacokinetics of 3-(6-methylpyridine-3-yl-sulfanyl)-6-(4H-[1,2,4]triazole-3-yl-sulfanyl)-N-(1,3-thiazole-2-yl)-2-pyridine carboxamide, a glucokinase activator, in rats caused by the genetic polymorphism of CYP2D1.
Hasegawa T, Eiki J, Chiba M. Drug Metab Dispos. 2014 Sep; 42(9):1548-55. Epub 2014 Jun 12.